Lyell Immunopharma Inc. (LYEL)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.70

2.29%

After-hours Dec 13, 2024, 06:31 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	130.00K	84.68M	10.65M	7.76M	657.00K
Cost of Revenue	-	16.47M	14.54M	7.47M	-
Gross Profit	130.00K	68.22M	-3.88M	281.00K	657.00K
Operating Income	-247.01M	-183.12M	-214.78M	-211.94M	-102.09M
Interest Income	23.45M	7.05M	1.17M	5.94M	8.12M
Pretax Income	-234.63M	-183.12M	-250.22M	-204.47M	-129.38M
Net Income	-234.63M	-4.75M	-285.50M	-198.53M	-121.26M
Selling & General & Admin	66.98M	117.31M	89.06M	46.88M	39.15M
Research & Development	182.94M	159.19M	138.69M	182.24M	63.59M
Other Expenses	-2.79M	1.89M	-2.32M	-9.43M	-35.41M
Operating Expenses	247.14M	276.50M	225.43M	219.69M	102.75M
Interest Expense	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	247.14M	276.50M	225.43M	219.69M	102.75M
Income Tax	-	-178.36M	35.28M	-5.94M	-8.12M
Shares Outstanding (Basic)	250.98M	247.08M	242.74M	246.58M	246.58M
Shares Outstanding (Diluted)	250.98M	247.08M	242.74M	246.58M	246.58M
EPS (Basic)	-0.93	-0.02	-1.18	-0.81	-0.49
EPS (Diluted)	-0.93	-0.02	-1.18	-0.81	-0.49
EBITDA	-226.76M	-166.65M	-199.94M	-207.64M	-100.83M
Depreciation & Amortization	20.25M	16.47M	14.54M	7.47M	4.38M